Croissy-Beaubourg and Montpellier, July 11, 2016 – THERADIAG (ISIN: FR0004197747, Ticker: ALTER, PEA-PME eligible), a company specializing in in vitro diagnostics and theranostics, is today announcing Vincent Fert’s appointment to the Company’s Board of Directors.Vincent Fert…
Another surge in sales of LISA TRACKER® kits: +150%74% of revenues generated by in-house products (internal) Croissy-Beaubourg and Montpellier, July 5, 2016 – Theradiag (ISIN: FR0004197747, Ticker: ALTER, PEA-PME eligible), a company specializing in in vitro…
Four biotherapy monitoring tests being marketed by Miraca Life SciencesThe largest range of tests available in the US market Croissy-Beaubourg and Montpellier, June 16, 2016 – Theradiag (ISIN: FR0004197747, Ticker: ALTER, eligible for PEA-PME savings…